AU5664694A - Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof - Google Patents

Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof

Info

Publication number
AU5664694A
AU5664694A AU56646/94A AU5664694A AU5664694A AU 5664694 A AU5664694 A AU 5664694A AU 56646/94 A AU56646/94 A AU 56646/94A AU 5664694 A AU5664694 A AU 5664694A AU 5664694 A AU5664694 A AU 5664694A
Authority
AU
Australia
Prior art keywords
lysine
pharmaceutical
methods
containing polypeptide
polypeptide compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56646/94A
Inventor
Lawrence R Green
Vadim T Ivanov
Vladimir K Khavinson
Alexander N Mikhaltsov
Inessa I Mikhalyova
Vyacheslav G Morozov
Nicolay V Sinackevich
Boris V Vaskovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTOVEN INTERNATIONAL NV
Original Assignee
Cytoven Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytoven Int Nv filed Critical Cytoven Int Nv
Publication of AU5664694A publication Critical patent/AU5664694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU56646/94A 1992-10-28 1993-10-28 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof Abandoned AU5664694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96763392A 1992-10-28 1992-10-28
US967633 1992-10-28
PCT/US1993/010341 WO1994009804A1 (en) 1992-10-28 1993-10-28 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
AU5664694A true AU5664694A (en) 1994-05-24

Family

ID=25513082

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56646/94A Abandoned AU5664694A (en) 1992-10-28 1993-10-28 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof

Country Status (2)

Country Link
AU (1) AU5664694A (en)
WO (1) WO1994009804A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297276A (en) * 1979-03-23 1981-10-27 Hoffman-La Roche Inc. Thymosin beta 3 and beta 4
DE3100974A1 (en) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Medicaments having immunoregulating action which contain thymosin alpha 1 fragments, and thymosin alpha 1 fragments
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus

Also Published As

Publication number Publication date
WO1994009804A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU6359594A (en) Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
AU3076189A (en) Novel compositions and methods of use thereof
AU5136093A (en) Peptide antagonists of sh2 binding and therapeutic uses thereof
AU673703B2 (en) Injector and use of the same
AU692612B2 (en) Peptide mixture and products thereof
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU5793396A (en) Human interferon tau compositions and methods of use
AU6017194A (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
AU6523194A (en) Compositions including heme-containing proteins and methods relating thereto
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU1193092A (en) Granulated pharmaceutical composition and method of obtaining it
AU633294B2 (en) Motilin-like polypeptide and use thereof
AU8316587A (en) Pharmaceutical compositions and their use
AU1751892A (en) Novel peptide compositions and uses therefor
AU1753892A (en) Mammalian gap-43 compositions and methods of use
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU651992B2 (en) Polyethylene terephthalate compositions and methods of using thereof
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
AU1432292A (en) Drug delivery composition and method of using the same
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU6518486A (en) Peptides and compositions
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof